COVID-19 crisis and cancer

Affiliations

¹ Department of Medicine I, Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
² First Medical Department, Center for Oncology, Hematology and Palliative Care, Clinic Ottakring, Pavillon 23, Monteleartstr. 37, 1160 Vienna, Austria.

Editorial

Rupert Bartsch et al. Memo. 2022.

. 2022;15(2):98-99.

doi: 10.1007/s12254-022-00812-x. Epub 2022 Jun 7.

¹ Department of Medicine I, Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
² First Medical Department, Center for Oncology, Hematology and Palliative Care, Clinic Ottakring, Pavillon 23, Monteleartstr. 37, 1160 Vienna, Austria.

No abstract available

Conflict of interest statement

Conflict of interestR. Bartsch and W. Hilbe declare that they have no competing interests.

1. Udovica S, Müser N, Pechlaner A, et al. High mortality in patients with active malignancy and severe COVID-19. memo. 2020 doi: 10.1007/s12254-022-00814-9. - DOI
1. Interview with Ivan Tancevski, MD, Department of Internal Medicine II, Medical University of Innsbruck, Austria—conducted by Anna Fenzl, PhD. Cardiopulmonary sequelae of COVID-19. memo. 2022;15(2). 10.1007/s12254-022-00802-z.
1. Salamoon M, Kenj M. Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report. memo. 2021 doi: 10.1007/s12254-021-00719-z. - DOI - PMC - PubMed